UFT (Tegafur and Uracil) as Postoperative Adjuvant Chemotherapy for Solid Tumors (Carcinoma of the Lung, Stomach, Colon/Rectum, and Breast) : Clinical Evidence, Mechanism of Action, and Future Direction
スポンサーリンク
概要
- 論文の詳細を見る
- 2007-11-01
著者
-
Tanaka Fumihiro
Department Of Thoracic Surgery Hyogo College Of Medicine
-
Tanaka Fumihiro
Department Of Applied Biosciences Nagoya University
関連論文
- Angiogenesis and the efficacy of postoperative administration of UFT in pathologic stage I non-small cell lung cancer
- Expression of Thymidylate Synthase in Human Non-small Cell Lung Cancer
- p53 Status Predicts the Efficacy of Postoperative Oral Administration of Tegafur for Completely Resected Non-small Cell Lung Cancer
- Stromal aminopeptidase N expression : correlation with angiogenesis in non-small-cell lung cancer
- UFT and S-1 for treatment of primary lung cancer
- Isolation and Characterization of an N-Linked Oligosaccharide That Is Significantly Increased in Sera from Patients with Non-Small Cell Lung Cancer
- Roles of the Dimethylamino Group and Macrodiolide Ring of Pamamycin-607 in Its Aerial Mycelium-inducing Activity
- Treatment of Necrotic Infection on the Anterior Chest Wall Secondary to Mastectomy and Postoperative Radiotherapy by the Application of Omentum and Mesh Skin Grafting : Report of a Case
- Lung Cancer-related Genes in the Blood
- Malignant mesothelioma : current status and perspective in Japan and the world
- UFT (Tegafur and Uracil) as Postoperative Adjuvant Chemotherapy for Solid Tumors (Carcinoma of the Lung, Stomach, Colon/Rectum, and Breast) : Clinical Evidence, Mechanism of Action, and Future Direction
- Alveolar Adenoma of the Lung : A Case Report